TARA MOSTOFI: Open Payments
NPI 1073728051 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,230 in 75 payments from 19 companies in 2025. Trend: 2023 $1,344 · 2024 $1,454 · 2025 $3,230
Food & beverage: $2,532Travel & lodging: $644Consulting: $39Education: $15
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $1,040 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $497 |
| AstraZeneca Pharmaceuticals LP | 13 | $384 |
| GENZYME CORPORATION | 7 | $285 |
| Regeneron Healthcare Solutions, Inc. | 4 | $207 |
| Amgen Inc. | 9 | $182 |
| Ionis Pharmaceuticals, Inc. | 3 | $102 |
| CSL Behring | 3 | $99 |
| Pharming Healthcare, Inc. | 2 | $94 |
| Genentech USA, Inc. | 3 | $71 |
Products named: Rhapsido, NEFFY, DUPIXENT, TEZSPIRE, FASENRA, DAWNZERA, RUCONEST, Hizentra.
Industry payments across CA — which companies pay providers there.
